199 related items for PubMed ID: 9787892
1. The lower limits of dexamethasone window in Chinese depressives.
Shiah IS, Ko HC, Lu RB.
Biol Psychiatry; 1998 Oct 01; 44(7):648-55. PubMed ID: 9787892
[Abstract] [Full Text] [Related]
2. Plasma dexamethasone concentrations and the dexamethasone suppression test.
Ritchie JC, Belkin BM, Krishnan KR, Nemeroff CB, Carroll BJ.
Biol Psychiatry; 1990 Jan 15; 27(2):159-73. PubMed ID: 2294980
[Abstract] [Full Text] [Related]
3. The plasma dexamethasone window: evidence supporting its usefulness to validate dexamethasone suppression test results.
O'Sullivan BT, Hunt GE, Johnson GF, Caterson ID.
Biol Psychiatry; 1989 Mar 15; 25(6):739-54. PubMed ID: 2923936
[Abstract] [Full Text] [Related]
4. Plasma dexamethasone concentrations and differential suppression response of cortisol and corticosterone in depressives and controls.
Holsboer F, Haack D, Gerken A, Vecsei P.
Biol Psychiatry; 1984 Mar 15; 19(3):281-91. PubMed ID: 6722226
[Abstract] [Full Text] [Related]
5. Effect of high plasma dexamethasone levels on DST sensitivity: dose-response study in depressed patients and controls.
Hunt GE, O'Sullivan BT, Johnson GF, Caterson ID.
Psychiatry Res; 1991 Feb 15; 36(2):209-22. PubMed ID: 2017535
[Abstract] [Full Text] [Related]
6. The influences of dexamethasone levels on the predictive value of the DST for unipolar major depression and the relationships between post-dexamethasone cortisol and ACTH levels.
Maes M, Minner B, Suy E.
J Affect Disord; 1989 Feb 15; 17(1):39-46. PubMed ID: 2544636
[Abstract] [Full Text] [Related]
7. Cortisol suppression per nanogram per milliliter of plasma dexamethasone in depressive and normal subjects.
Carson SW, Halbreich U, Yeh CM, Asnis G, Goldstein S.
Biol Psychiatry; 1988 Sep 15; 24(5):569-77. PubMed ID: 3167145
[Abstract] [Full Text] [Related]
8. A longitudinal evaluation of dexamethasone and cortisol plasma concentrations in the dexamethasone suppression test before and during treatment with antidepressant drugs.
Guthrie SK, Vartanian L, Grunhaus L, Hariharan M, Pande A, Haskett RF.
Acta Psychiatr Scand; 1990 Dec 15; 82(6):427-32. PubMed ID: 2291411
[Abstract] [Full Text] [Related]
9. The effect of age on cortisol and plasma dexamethasone concentrations in depressed patients and controls.
Hunt GE, Johnson GF, Caterson ID.
J Affect Disord; 1989 Dec 15; 17(1):21-32. PubMed ID: 2525575
[Abstract] [Full Text] [Related]
10. An augmented escape of androstenedione from suppression by dexamethasone in melancholia: relationships to intact ACTH and cortisol nonsuppression.
Maes M, Van Gastel A, Blockx P, Martin M, Cosyns P, Scharpé S, Desnyder R.
J Affect Disord; 1995 Aug 18; 34(4):291-300. PubMed ID: 8550955
[Abstract] [Full Text] [Related]
11. Dexamethasone kinetics in depressed patients before and after clinical response.
Maguire KP, Tuckwell VM, Schweitzer I, Tiller JW, Davies BM.
Psychoneuroendocrinology; 1990 Aug 18; 15(2):113-23. PubMed ID: 2359809
[Abstract] [Full Text] [Related]
12. A modified dexamethasone suppression test for endogenous depression.
Poland RE, Rubin RT, Lane LA, Martin DJ, Rose DE, Lesser IM.
Psychiatry Res; 1985 Aug 18; 15(4):293-9. PubMed ID: 3865246
[Abstract] [Full Text] [Related]
13. Pharmacokinetics of dexamethasone and its relationship to dexamethasone suppression test outcome in depressed patients and healthy control subjects.
O'Sullivan BT, Cutler DJ, Hunt GE, Walters C, Johnson GF, Caterson ID.
Biol Psychiatry; 1997 Mar 01; 41(5):574-84. PubMed ID: 9046990
[Abstract] [Full Text] [Related]
14. Chronic caffeine consumption and the dexamethasone suppression test in depression.
Lee MA, Flegel P, Cameron OG, Greden JF.
Psychiatry Res; 1988 Apr 01; 24(1):61-5. PubMed ID: 3393618
[Abstract] [Full Text] [Related]
15. Serial dexamethasone suppression tests in initial suppressors and nonsuppressors treated with electroconvulsive therapy.
Devanand DP, Decina P, Sackeim HA, Hopkins N, Novacenko H, Malitz S.
Biol Psychiatry; 1987 Apr 01; 22(4):463-72. PubMed ID: 3567261
[Abstract] [Full Text] [Related]
16. Plasma cortisol and 11-deoxycortisol activity in depressed patients and normal volunteers.
Schweitzer I, Tuckwell VM, Maguire KP, Tiller JW, Harrison LC, Davies BM.
Psychoneuroendocrinology; 1991 Apr 01; 16(5):375-82. PubMed ID: 1805291
[Abstract] [Full Text] [Related]
17. Monoamine oxidase and cortisol response in depression and schizophrenia.
Pandey GN, Sharma RP, Janicak PG, Davis JM.
Psychiatry Res; 1992 Oct 01; 44(1):1-8. PubMed ID: 1461943
[Abstract] [Full Text] [Related]
18. HPA hyperactivity with increased plasma cortisol affects dexamethasone metabolism and DST outcome.
Stokes PE, Sikes C, Lasley B, Stoll P.
J Psychiatr Res; 2002 Oct 01; 36(6):417-21. PubMed ID: 12393311
[Abstract] [Full Text] [Related]
19. Plasma dexamethasone levels in children given the dexamethasone suppression test.
Naylor MW, Greden JF, Alessi NE.
Biol Psychiatry; 1990 Mar 15; 27(6):592-600. PubMed ID: 2322618
[Abstract] [Full Text] [Related]
20. Use of the dexamethasone suppression test in an inpatient setting: a replication and new findings.
Maes M, De Ruyter M, Suy E.
Psychoneuroendocrinology; 1989 Mar 15; 14(3):231-9. PubMed ID: 2756075
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
